CPEX Pharma to be bought by Footstar for $76.6 million
This article was originally published in Scrip
Executive Summary
CPEX Pharmaceuticals, a US specialty pharma company based in Exeter, New Hampshire, has entered into an agreement with FCB I Holdings, a newly formed company controlled by Delaware-based Footstar Corporation, under which FCB, through a wholly owned subsidiary, will acquire the firm for about $76.6 million in cash.